Supriya Lifescience Ltd., a leading name in the API manufacturing sector and known for its adherence to cGMP standards, has expanded its commitment to sustainability by inaugurating a new 5 MWp solar power facility in Nanded District, Maharashtra. Dr Satish Wagh, Chairman of Supriya Lifescience, inaugurated the facility and reiterated the company’s focus on renewable energy and environmental responsibility.
This solar project is a part of the company’s broader initiative to reduce the carbon footprint of its operations. With the addition of this 5 MWp solar facility, Supriya Lifescience’s total solar energy capacity now stands at 9.85 MWp, including the previously installed 4.85 MWp in Solapur District, Maharashtra. These efforts contribute to India’s broader climate goals by reducing dependence on fossil fuels and promoting cleaner, more sustainable energy sources.
Dr Satish Wagh, Chairman and Whole Time Director of Supriya Lifescience, highlighted, “Adopting renewable energy is more than just a business strategy; it is a commitment to a sustainable future. Our investments in solar power are central to our long-term vision of reducing environmental impact and fostering growth in a responsible manner.”
The Nanded solar project was carried out in collaboration with Enrich Energy Pvt. Ltd., a recognized leader in the renewable energy sector. The successful integration of solar power into Supriya Lifescience’s operations marks a significant step forward in enhancing energy efficiency within the pharmaceutical manufacturing industry, aligning with global best practices for sustainability.
As a prominent player in the pharmaceutical industry, Supriya Lifescience continues to prioritize sustainability, with solar energy playing a key role in reducing greenhouse gas emissions and supporting India’s renewable energy targets. Founded in 1987, Supriya Lifescience is a renowned producer of active pharmaceutical ingredients, with a state-of-the-art facility certified by international health authorities including Health Canada, EU GMP, US FDA, and more. The company remains dedicated to ethical principles and environmental responsibility, focusing on both innovation and sustainability.
